| Ruxoltinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease. M Zeiser, R., Von Bubnoff, N., Butler, J., Mohty M., Elemary N England J Med 382 (19), 1800-1810, 2020 | 556* | 2020 |
| Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from … I Walker, T Panzarella, S Couban, F Couture, G Devins, M Elemary, ... The Lancet Oncology 17 (2), 164-173, 2016 | 327 | 2016 |
| Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial MV Mateos, H Blacklock, F Schjesvold, A Oriol, D Simpson, A George, ... The Lancet Haematology 6 (9), e459-e469, 2019 | 221 | 2019 |
| Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial SZ Usmani, F Schjesvold, A Oriol, L Karlin, M Cavo, RM Rifkin, HA Yimer, ... The Lancet Haematology 6 (9), e448-e458, 2019 | 202 | 2019 |
| Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study R Buckstein, RA Wells, N Zhu, HA Leitch, TJ Nevill, KWL Yee, B Leber, ... British journal of haematology 174 (1), 88-101, 2016 | 88 | 2016 |
| Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion … HA Leitch, A Parmar, RA Wells, L Chodirker, N Zhu, TJ Nevill, KWL Yee, ... British Journal of Haematology 179 (1), 83-97, 2017 | 77 | 2017 |
| Impact of transfusion on cancer growth and outcome HA Goubran, M Elemary, M Radosevich, J Seghatchian, M El-Ekiaby, ... Cancer growth and metastasis 9, CGM. S32797, 2016 | 77 | 2016 |
| Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing … I Walker, T Panzarella, S Couban, F Couture, G Devins, M Elemary, ... The Lancet Haematology 7 (2), e100-e111, 2020 | 70 | 2020 |
| Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial J Tay, DS Allan, E Chatelain, D Coyle, M Elemary, A Fulford, W Petrcich, ... American Society of Clinical Oncology, 2020 | 46 | 2020 |
| Hematopoietic stem cell transplantation in Egypt HK Mahmoud, AM El-Haddad, OA Fahmy, M El-Emary, A Nassar, ... Bone marrow transplantation 42 (1), S76-S80, 2008 | 45 | 2008 |
| Canadian Blood and Marrow Transplant Group. Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing … I Walker, T Panzarella, S Couban, F Couture, G Devins, M Elemary, ... Lancet Oncol 17 (2), 164-173, 2016 | 41 | 2016 |
| Impact of intensity of conditioning therapy in patients aged 40–60 years with AML/myelodysplastic syndrome undergoing allogeneic transplantation MA Khabori, M El-Emary, W Xu, G Guyatt, A Galal, J Kuruvilla, J Lipton, ... Bone marrow transplantation 46 (4), 516-522, 2011 | 38 | 2011 |
| Vitamin B12 deficiency and metabolism-mediated thrombotic microangiopathy (MM-TMA) W Sabry, M Elemary, T Burnouf, J Seghatchian, H Goubran Transfusion and Apheresis Science 59 (1), 102717, 2020 | 37 | 2020 |
| An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring R Starkman, S Alibhai, RA Wells, M Geddes, N Zhu, MM Keating, B Leber, ... Leukemia 34 (5), 1394-1406, 2020 | 31 | 2020 |
| Iron overload in myelodysplastic syndromes: evidence based guidelines from the Canadian consortium on MDS HA Leitch, R Buckstein, N Zhu, TJ Nevill, KWL Yee, B Leber, MM Keating, ... Leukemia Research 74, 21-41, 2018 | 26 | 2018 |
| Treatment of older patients with acute myeloid leukemia (AML): revised Canadian consensus guidelines JM Brandwein, N Zhu, R Kumar, B Leber, M Sabloff, I Sandhu, J Kassis, ... American journal of blood research 7 (4), 30, 2017 | 23 | 2017 |
| Transfusion of red cells in hematopoietic stem cell transplantation (TRIST study): a randomized controlled trial evaluating 2 red cell transfusion thresholds J Tay, DS Allan, E Chatelain, D Coyle, M Elemary, W Petrcich, T Ramsay, ... Blood 128 (22), 1032, 2016 | 23 | 2016 |
| Transfusion challenges in hematology oncology and hematopoietic stem cell transplant–literature review and local experience M Elemary, J Seghatchian, J Stakiw, M Bosch, W Sabry, H Goubran Transfusion and Apheresis Science 56 (3), 317-321, 2017 | 20 | 2017 |
| A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry BL Houston, J Jayakar, RA Wells, M Lenis, L Zhang, N Zhu, HA Leitch, ... Annals of hematology 96, 2025-2029, 2017 | 19 | 2017 |
| BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy L Hahn, H Lim, T Dusyk, W Sabry, M Elemary, J Stakiw, P Danyluk, ... Scientific reports 11 (1), 14071, 2021 | 18 | 2021 |
